These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 9863483)

  • 1. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.
    Rosenberg WM; Prince C; Kaklamanis L; Fox SB; Jackson DG; Simmons DL; Chapman RW; Trowell JM; Jewell DP; Bell JI
    Lancet; 1995 May; 345(8959):1205-9. PubMed ID: 7537840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.
    Camacho FI; Muñoz C; Sánchez-Verde L; Sáez AI; Alcántara M; Rodríguez R
    Histopathology; 1999 Aug; 35(2):144-9. PubMed ID: 10460659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44v6 in ulcerative colitis and Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Adolf GR
    Lancet; 1996 Apr; 347(9007):1049. PubMed ID: 8606594
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiating ulcerative colitis from Crohn's disease: false dawn for CD44.
    Spencer J
    Gut; 1998 Sep; 43(3):310-1. PubMed ID: 9863469
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological markers to differentiate between ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Meuwissen SG; von Blomberg BM; van de Merwe JP; Devillé WL; Fonk JC; Peña AS
    J Clin Pathol; 1995 Apr; 48(4):346-50. PubMed ID: 7615855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
    Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
    United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.
    Mahida YR; Kurlac L; Gallagher A; Hawkey CJ
    Gut; 1991 Dec; 32(12):1531-4. PubMed ID: 1773961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological differentiation of inflammatory bowel diseases.
    Conrad K; Schmechta H; Klafki A; Lobeck G; Uhlig HH; Gerdi S; Henker J
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):129-35. PubMed ID: 11981336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serodiagnosis of Crohn's disease].
    Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S
    Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S; Florén CH; Lindhagen T; Starck M; Stewenius J; Nässberger L
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.